Spots Global Cancer Trial Database for Lymphocytes Subpopulation in Cancer Patients
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Lymphocytes Subpopulation in Cancer Patients
Official Title: Lymphocytes Subpopulation and Its Relevance With Tumor Grade and Prognosis in Cancer Patients
Study ID: NCT02516371
Conditions
Interventions
Study Description
Brief Summary: This study aims to exam the subpopulation of lymphocytes and evaluate the clinico-pathologic correlations.
Detailed Description: The host's inflammatory response in the tumor microenvironment could effect cancer progression and prognosis. As components of systemic inflammatory response, lymphocytes, neutrophils, and platelets are being recognised to have an important role in carcinogenesis and tumor progression. To date, a number of peripheral blood-derived inflammation-based scores such as the neutrophil-lymphocyte ratio (NLR), platelet- lymphocyte ratio (PLR) and so on have been proposed as prognostic markers in numerous types of cancers. But, very little is known of their impact in subpopulation of lymphocytes. The investigators try to evaluate the activity of lymphocytes in peripheral blood and find out the relationship among clinical prognosis.
Keywords
Eligibility
Minimum Age: 20 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Uijeongbu St. Mary's hospital, the Catholic university of Korea, Uijeongbu city, Gyounggido, Korea, Republic of
Contact Details
Name: Yoon Ho Ko, MD, PhD
Affiliation: Uijeongbu St. Mary's Hospital, The Catholic University of Korea
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
